↓ Skip to main content

Informed choice about breast cancer prevention: randomized controlled trial of an online decision aid intervention.

Overview of attention for article published in Breast Cancer Research, September 2013
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
95 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Informed choice about breast cancer prevention: randomized controlled trial of an online decision aid intervention.
Published in
Breast Cancer Research, September 2013
DOI 10.1186/bcr3468
Pubmed ID
Authors

Korfage IJ, Fuhrel-Forbis A, Ubel PA, Zikmund-Fisher BJ, Greene SM, McClure JB, Smith DM, Hensly Alford S, Fagerlin A, Ida J Korfage, Andrea Fuhrel-Forbis, Peter A Ubel, Brian J Zikmund-Fisher, Sarah M Greene, Jennifer B McClure, Dylan M Smith, Sharon Hensley Alford, Angela Fagerlin

Abstract

Tamoxifen and raloxifene are chemopreventive drugs that can reduce women’s relative risk of primary breast cancer by 50%; however, most women eligible for these drugs have chosen not to take them. The reasons for low uptake may be related to women’s knowledge or attitudes towards the drugs. We aimed to examine the impact of an online breast cancer chemoprevention decision aid (DA) on informed intentions and decisions of women at high risk of breast cancer.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
United Kingdom 1 1%
Unknown 92 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 15 16%
Researcher 13 14%
Other 10 11%
Student > Bachelor 9 9%
Student > Ph. D. Student 8 8%
Other 22 23%
Unknown 18 19%
Readers by discipline Count As %
Medicine and Dentistry 32 34%
Psychology 10 11%
Nursing and Health Professions 9 9%
Agricultural and Biological Sciences 5 5%
Social Sciences 3 3%
Other 11 12%
Unknown 25 26%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 September 2014.
All research outputs
#17,252,835
of 21,347,686 outputs
Outputs from Breast Cancer Research
#1,562
of 1,842 outputs
Outputs of similar age
#132,313
of 179,949 outputs
Outputs of similar age from Breast Cancer Research
#34
of 41 outputs
Altmetric has tracked 21,347,686 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one is in the 7th percentile – i.e., 7% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 179,949 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one is in the 4th percentile – i.e., 4% of its contemporaries scored the same or lower than it.